Unknown

Dataset Information

Patients with Type 2 Diabetes and Residual Insulin Secretory Capacity Realize Glycemic Benefits from Real-Time Continuous Glucose Monitoring.


ABSTRACT:

SUBMITTER: Puhr S 

PROVIDER: S-EPMC8258531 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature